ArticleThe British journal of dermatology2022
Response to 'Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT)'.
K Yatsuzuka et al.PubMed ↗Publisher ↗
No numbers read from the abstract.